Matches in Wikidata for { <http://www.wikidata.org/entity/Q37221184> ?p ?o ?g. }
- Q37221184 description "article científic" @default.
- Q37221184 description "article scientifique" @default.
- Q37221184 description "articolo scientifico" @default.
- Q37221184 description "artigo científico" @default.
- Q37221184 description "artículu científicu espublizáu en 2008" @default.
- Q37221184 description "bilimsel makale" @default.
- Q37221184 description "scientific article published on 17 July 2008" @default.
- Q37221184 description "vedecký článok" @default.
- Q37221184 description "vetenskaplig artikel" @default.
- Q37221184 description "videnskabelig artikel" @default.
- Q37221184 description "vědecký článek" @default.
- Q37221184 description "wetenschappelijk artikel" @default.
- Q37221184 description "wissenschaftlicher Artikel" @default.
- Q37221184 description "наукова стаття, опублікована в липні 2008" @default.
- Q37221184 description "научни чланак" @default.
- Q37221184 description "مقالة علمية نشرت في 17 يوليو 2008" @default.
- Q37221184 name "Phase II study of intravesical therapy with AD32 in patients with papillary urothelial carcinoma or carcinoma in situ (CIS) refractory to prior therapy with bacillus Calmette-Guerin (E3897): a trial of the Eastern Cooperative Oncology Group" @default.
- Q37221184 name "Phase II study of intravesical therapy with AD32 in patients with papillary urothelial carcinoma or carcinoma in situ (CIS) refractory to prior therapy with bacillus Calmette-Guerin (E3897): a trial of the Eastern Cooperative Oncology Group" @default.
- Q37221184 name "Phase II study of intravesical therapy with AD32 in patients with papillary urothelial carcinoma or carcinoma in situ" @default.
- Q37221184 type Item @default.
- Q37221184 label "Phase II study of intravesical therapy with AD32 in patients with papillary urothelial carcinoma or carcinoma in situ (CIS) refractory to prior therapy with bacillus Calmette-Guerin (E3897): a trial of the Eastern Cooperative Oncology Group" @default.
- Q37221184 label "Phase II study of intravesical therapy with AD32 in patients with papillary urothelial carcinoma or carcinoma in situ (CIS) refractory to prior therapy with bacillus Calmette-Guerin (E3897): a trial of the Eastern Cooperative Oncology Group" @default.
- Q37221184 label "Phase II study of intravesical therapy with AD32 in patients with papillary urothelial carcinoma or carcinoma in situ" @default.
- Q37221184 prefLabel "Phase II study of intravesical therapy with AD32 in patients with papillary urothelial carcinoma or carcinoma in situ (CIS) refractory to prior therapy with bacillus Calmette-Guerin (E3897): a trial of the Eastern Cooperative Oncology Group" @default.
- Q37221184 prefLabel "Phase II study of intravesical therapy with AD32 in patients with papillary urothelial carcinoma or carcinoma in situ (CIS) refractory to prior therapy with bacillus Calmette-Guerin (E3897): a trial of the Eastern Cooperative Oncology Group" @default.
- Q37221184 prefLabel "Phase II study of intravesical therapy with AD32 in patients with papillary urothelial carcinoma or carcinoma in situ" @default.
- Q37221184 P1433 Q37221184-859E5667-BD34-4578-A544-FF252A8B4FA8 @default.
- Q37221184 P1476 Q37221184-87F5A5C9-5D46-4FED-A184-F7DC42B7CB81 @default.
- Q37221184 P2093 Q37221184-026AE67D-DABB-45FA-AA94-DBD6296D0595 @default.
- Q37221184 P2093 Q37221184-270B1513-4FCC-49ED-8D67-F8322EDEE086 @default.
- Q37221184 P2093 Q37221184-5D496E6B-35CE-4766-BB2D-579904E9D60C @default.
- Q37221184 P2093 Q37221184-C9AAD153-24C3-4935-80BB-4A746BD59587 @default.
- Q37221184 P2093 Q37221184-EDF16C94-F975-4A99-99AB-035A2C2B24B9 @default.
- Q37221184 P2860 Q37221184-01980D47-FFDB-4D38-9AC6-6FAD7C3DCAA9 @default.
- Q37221184 P2860 Q37221184-0993E3C5-7C7C-4107-BDBA-D05F38156221 @default.
- Q37221184 P2860 Q37221184-26B53F9D-7D48-4304-9FCF-9F69A146060B @default.
- Q37221184 P2860 Q37221184-27274DA6-32C6-4480-9D77-B257E24E9F89 @default.
- Q37221184 P2860 Q37221184-3276B70A-F717-4935-8A1B-9192B279A70D @default.
- Q37221184 P2860 Q37221184-328CA48C-BED4-4F05-8617-CB5147DC7E45 @default.
- Q37221184 P2860 Q37221184-3E8D7136-4B90-4D93-A075-222363D83334 @default.
- Q37221184 P2860 Q37221184-46623FA0-96CF-483B-8E4A-83F030D54E4C @default.
- Q37221184 P2860 Q37221184-78B1C9F1-5E0C-446D-810D-CECC27820421 @default.
- Q37221184 P2860 Q37221184-7C2DAB3E-5A0A-4A4E-8AF7-5DC28C7C3A08 @default.
- Q37221184 P2860 Q37221184-7F645B44-5C5A-4AC5-A8B0-EE119000142E @default.
- Q37221184 P2860 Q37221184-95ECD9ED-C7A3-4315-AB65-835FA19F67BE @default.
- Q37221184 P2860 Q37221184-AD4A792C-840C-4812-BE58-B1177D9DC9B5 @default.
- Q37221184 P2860 Q37221184-B4FCEE47-BE50-46B8-B346-7906DCCCE2CC @default.
- Q37221184 P2860 Q37221184-BDF859EB-5B43-4B0E-BD06-CE119069732B @default.
- Q37221184 P2860 Q37221184-CC350ACF-761B-4F35-94DD-B5084EF6F166 @default.
- Q37221184 P2860 Q37221184-D1E20D9C-1F9A-4757-9C23-B48BA6E52B5E @default.
- Q37221184 P2860 Q37221184-DAE18FB8-FB94-4E36-A869-A111498785DE @default.
- Q37221184 P2860 Q37221184-E1C60A5F-2FC0-4602-BAD5-B8F3F60F0F08 @default.
- Q37221184 P2860 Q37221184-F9E5DCC2-D095-4AE2-8D16-AB7C023602F0 @default.
- Q37221184 P2860 Q37221184-FCB81245-B7B5-42B7-8E38-5602A40DFAEA @default.
- Q37221184 P304 Q37221184-05DE23A6-EFC0-4798-9D80-48AD577FD97D @default.
- Q37221184 P31 Q37221184-2E53F925-AD38-4D7C-92B7-5E8FA04A8B0B @default.
- Q37221184 P356 Q37221184-E5CA2A76-E75B-4B6F-B090-4384DC34AC79 @default.
- Q37221184 P433 Q37221184-18EA40B5-24AF-4F5F-BC33-04E6E00F07E3 @default.
- Q37221184 P478 Q37221184-B17C2729-4C49-4C83-BD84-536A86810872 @default.
- Q37221184 P50 Q37221184-4101C23A-E1C8-4C5D-A2BD-D8E71769B6F7 @default.
- Q37221184 P577 Q37221184-89891FF7-24FE-400C-8D93-C3E53ACFE82E @default.
- Q37221184 P5875 Q37221184-E40B6A1E-1F94-4EB6-95FA-952C8C0404F6 @default.
- Q37221184 P698 Q37221184-3AA86752-C624-414D-B73F-2F0B886B19F4 @default.
- Q37221184 P921 Q37221184-8D208510-8988-4082-B478-75D2C06E5DC3 @default.
- Q37221184 P932 Q37221184-F80688E7-082B-4A95-AAF7-71811DD9335A @default.
- Q37221184 P356 J.UROLONC.2008.05.004 @default.
- Q37221184 P698 18639470 @default.
- Q37221184 P1433 Q2113446 @default.
- Q37221184 P1476 "Phase II study of intravesical therapy with AD32 in patients with papillary urothelial carcinoma or carcinoma in situ (CIS) refractory to prior therapy with bacillus Calmette-Guerin (E3897): a trial of the Eastern Cooperative Oncology Group" @default.
- Q37221184 P2093 "Edward M Messing" @default.
- Q37221184 P2093 "Jeffrey M Ignatoff" @default.
- Q37221184 P2093 "Julio M Pow-Sang" @default.
- Q37221184 P2093 "Richard Evan Greenberg" @default.
- Q37221184 P2093 "Yu-Hui Chen" @default.
- Q37221184 P2860 Q28283632 @default.
- Q37221184 P2860 Q33781023 @default.
- Q37221184 P2860 Q34342138 @default.
- Q37221184 P2860 Q35803810 @default.
- Q37221184 P2860 Q35879902 @default.
- Q37221184 P2860 Q36768929 @default.
- Q37221184 P2860 Q40506004 @default.
- Q37221184 P2860 Q41380595 @default.
- Q37221184 P2860 Q41673677 @default.
- Q37221184 P2860 Q43692777 @default.
- Q37221184 P2860 Q44713894 @default.
- Q37221184 P2860 Q45141955 @default.
- Q37221184 P2860 Q70776060 @default.
- Q37221184 P2860 Q72023587 @default.
- Q37221184 P2860 Q73139162 @default.
- Q37221184 P2860 Q73280015 @default.
- Q37221184 P2860 Q73851060 @default.
- Q37221184 P2860 Q74107594 @default.
- Q37221184 P2860 Q74654761 @default.
- Q37221184 P2860 Q79779625 @default.
- Q37221184 P2860 Q80275684 @default.
- Q37221184 P304 "496-501" @default.
- Q37221184 P31 Q13442814 @default.
- Q37221184 P356 "10.1016/J.UROLONC.2008.05.004" @default.
- Q37221184 P433 "5" @default.
- Q37221184 P478 "27" @default.